Daan Westenbrink

dr.

If you made any changes in Pure these will be visible here soon.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

Lanceren website young heart institute
Westenbrink, D., 2021
Research output: Non-textual form › Web publication/site › Academic
Ontwikkeling van brand indetity, vormgeving website Groningen cardiology
Westenbrink, D., 2021
Research output: Other contribution › Academic
Testosterone activates glucose metabolism through AMPK and androgen signaling in cardiomyocyte hypertrophy
Troncoso, M. F., Pavez, M., Wilson, C., Lagos, D., Duran, J., Ramos, S., Barrientos, G., Silva, P., Llanos, P., Basualto-Alarcon, C., Westenbrink, B. D., Lavandero, S. & Estrada, M., 5-Dec-2021, In: Biological research. 54, 1, 16 p., 3.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File
Aortic regurgitation, a forgotten valve disease in hypertrophic cardiomyopathy?
Westenbrink, B. D., de Boer, R. A. & Vliegenthart, R., May-2020, In: European Journal of Radiology. 126, 2 p., 108971.
Research output: Contribution to journal › Letter › Academic › peer-review
Association of beta-hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort
Flores-Guerrero, J. L., Westenbrink, B. D., Connelly, M. A., Otvos, J. D., Groothof, D., Shalaurova, I., Garcia, E., Navis, G., de Boer, R. A., Bakker, S. J. L. & Dullaart, R. P. F., 18-Dec-2020, In: European Journal of Clinical Investigation. p. 1-11 11 p., 13468.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File

38 Downloads (Pure)

Role of ATPase inhibitory factor 1 in heart failure development
Daan Westenbrink (Speaker)
30-Jan-2021
Activity: Talk and presentation › Academic event › Academic
SGLT2-inhibitors for HFpEF?
Daan Westenbrink (Speaker)
29-Aug-2020
Activity: Talk and presentation › Academic event › Academic
Social media commissie voor UMCG cardiology research center (External organisation)
Daan Westenbrink (Member)
2020 → 2021
Activity: Membership › Academic
SGLT2 inhibitors: mode of mechanism and CVOTs
Daan Westenbrink (Speaker)
25-Jun-2020 → 26-Jun-2020
Activity: Talk and presentation › Academic event › Academic
Are the beneficial effects of SGLT2-inhibitors in heart failure dependent on enhanced ketone metabolism?
Daan Westenbrink (Speaker)
31-Aug-2020 → 1-Sep-2020
Activity: Talk and presentation › Academic event › Academic